BioCentury
ARTICLE | Company News

Fresenius, Novo deal

July 21, 2014 7:00 AM UTC

Xellia Pharmaceuticals, which is wholly owned by Novo, acquired the Raleigh, N.C., freeze-dried vial manufacturing facility of Fresenius’ Fresenius Kabi USA LLC subsidiary. Xellia said it will retain ...